Dual Targeted Therapy with p53 siRNA and Epigallocatechingallate in a Triple Negative Breast Cancer Cell Model
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dual Targeted Therapy with p53 siRNA and Epigallocatechingallate in a Triple Negative Breast Cancer Cell Model
Authors
Keywords
Apoptosis, Cancer treatment, Small interfering RNAs, Cytokines, Breast cancer, Autophagic cell death, Angiogenesis, Gene expression
Journal
PLoS One
Volume 10, Issue 4, Pages e0120936
Publisher
Public Library of Science (PLoS)
Online
2015-04-08
DOI
10.1371/journal.pone.0120936
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The role for autophagy in cancer
- (2015) Eileen White JOURNAL OF CLINICAL INVESTIGATION
- Autophagy Inhibition Augments the Anticancer Effects of Epirubicin Treatment in Anthracycline-Sensitive and -Resistant Triple-Negative Breast Cancer
- (2014) S. Chittaranjan et al. CLINICAL CANCER RESEARCH
- Involvement of p38 in signal switching from autophagy to apoptosis via the PERK/eIF2α/ATF4 axis in selenite-treated NB4 cells
- (2014) Q Jiang et al. Cell Death & Disease
- Phosphorylated AKT inhibits the apoptosis induced by DRAM-mediated mitophagy in hepatocellular carcinoma by preventing the translocation of DRAM to mitochondria
- (2014) K Liu et al. Cell Death & Disease
- The anti-tumor efficiency of pterostilbene is promoted with a combined treatment of Fas signaling or autophagy inhibitors in triple negative breast cancer cells
- (2014) Wei-Chih Chen et al. Food & Function
- (-)-Epigallocatechin-3-Gallate Induces Apoptosis and Inhibits Invasion and Migration of Human Cervical Cancer Cells
- (2013) Chhavi Sharma et al. Asian Pacific Journal of Cancer Prevention
- Another review on triple negative breast cancer. Are we on the right way towards the exit from the labyrinth?
- (2013) Roxana Chiorean et al. BREAST
- Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
- (2013) J. Ferlay et al. EUROPEAN JOURNAL OF CANCER
- Epigallocatechin-3-Gallate (EGCG) Inhibits Cell Proliferation and Migratory Behaviour of Triple Negative Breast Cancer Cells
- (2013) Cornelia Braicu et al. JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
- p53siRNA therapy reduces cell proliferation, migration and induces apoptosis in triple negative breast cancer cells
- (2013) Cornelia Braicu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- The Potential Role of Nanotechnology in Therapeutic Approaches for Triple Negative Breast Cancer
- (2013) Rebecca Johnson et al. Pharmaceutics
- The rebel angel: mutant p53 as the driving oncogene in breast cancer
- (2012) D. Walerych et al. CARCINOGENESIS
- Mutant p53: one name, many proteins
- (2012) W. A. Freed-Pastor et al. GENES & DEVELOPMENT
- Epigallocatechin gallate induce cell death and apoptosis in triple negative breast cancer cells Hs578T
- (2012) Cornelia Braicu et al. JOURNAL OF DRUG TARGETING
- A Natural Small Molecule Harmine Inhibits Angiogenesis and Suppresses Tumour Growth through Activation of p53 in Endothelial Cells
- (2012) Fujun Dai et al. PLoS One
- Triple negative breast cancer: unmet medical needs
- (2010) Sumanta Kumar Pal et al. BREAST CANCER RESEARCH AND TREATMENT
- Application of Doxorubicin-induced rAAV2-p53 gene delivery in combined chemotherapy and gene therapy for hepatocellular carcinoma
- (2010) Chun-Ann Chen et al. CANCER BIOLOGY & THERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More